Gamma/Scintillation Cameras: A Global Strategic Business Report
San Jose, California (PRWEB) November 18, 2011
Follow us on LinkedIn – Nuclear imaging procedures are generally employed to detect cancerous growths, for the prognosis of susceptibility to brain disorders, and for the clinical assessment of cardiac risk. Rising incidences of cardiac arrests and brain disorders, increasing propensity to acquire cancerous growths and ageing population are resulting in heightening health concerns and popularizing preventive medicine among the medical fraternity and patient groups. Consequently, the penetration of gamma scintillation cameras is increasing due to increasing number of periodic diagnostic tests performed. The Gamma/Scintillation Cameras market has been actively contributing to the development of nuclear medicine field and as a result, has accomplished high levels of penetration and sophistication. However, the high penetration levels limit market opportunities to sophisticated upgrades and aftermarket parts, which comprise more than half the equipment market. Additionally, the rising popularity of PET procedures is seemingly threatening the future of the Gamma/Scintillation Cameras in the traditional imaging arena. Innovative applications and advancements in technology are the only routes to drive sales of the new equipment.
As stated by the new market research report on Gamma/Scintillation Cameras, the US is the world’s largest market. Europe, driven by innovation, integration, sophistication and digitalization of equipment is the second largest regional market. Asia-Pacific emerges as the fastest growing region for Gamma/Scintillation Cameras displaying a CAGR of 2.2% over the analysis period. Economic resurgence, improving healthcare scenario, and rising personal disposable incomes are presenting opportunities for the medical technology companies to capitalize in these under-penetrated markets. Product wise, Gamma Cameras represents the largest product segment. Displaying a CAGR of 3.5% over the analysis period, Nuclear medicine patient tables is the fastest growing product segment. Nuclear cardiac procedures and alarming propensities to malignant cancerous growths are driving the market.
Major players profiled in the report include Acrorad Co., Ltd., Digirad Corporation, Dilon Technologies, LLC, Gamma Medica-Ideas, Inc., GE Healthcare UK Ltd., Mediso Medical Imaging Systems, Nuclear Cardiology Systems, Inc., Positron Corporation, Philips Healthcare, Siemens Healthcare, among others.
The research report titled “Gamma/Scintillation Cameras: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of trends, issues, strategic industry activities, and profiles of major companies worldwide. The study analyzes market data and analytics in terms of value sales in US$ Million for the global market by the following regions - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), the Middle East, Latin America, and Rest of World. Key product segments analyzed include Gamma Cameras, Collimators, Gantry, Nuclear Medicine Patient Tables, Computerized Video Display Consoles, and Computer Workstations.
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Gamma_Scintillation_Cameras_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/